002550 千紅製藥
按盤價 
8.540 +0.780 (+10.052%)
8.540 +0.780 (+10.052%) | 2025/03 - 三個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 6.196 | 14.320 | 7.415 | 14.130 | 8.608 |
| 總資產報酬率 ROA (%) | 5.571 | 12.723 | 6.528 | 12.171 | 7.301 |
| 投入資產回報率 ROIC (%) | 6.125 | 14.028 | 7.138 | 13.454 | 8.285 | 邊際利潤分析 |
| 銷售毛利率 (%) | 54.396 | 54.852 | 43.265 | 38.591 | 44.462 |
| 營業利潤率 (%) | 41.481 | 25.972 | 11.264 | 15.628 | 11.165 |
| 息稅前利潤/營業總收入 (%) | 41.142 | 25.137 | 10.866 | 12.422 | 11.465 |
| 淨利潤/營業總收入 (%) | 34.956 | 21.830 | 9.848 | 13.888 | 9.939 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 66.627 | 74.144 | 72.829 | 86.680 | 70.290 |
| 價值變動淨收益/利潤總額(%) | 2.083 | 3.509 | 4.312 | -1.273 | 0.306 |
| 營業外收支淨額/利潤總額(%) | 0.002 | -0.139 | -0.409 | 0.090 | 0.019 | 償債能力分析 |
| 流動比率 (X) | 10.220 | 7.582 | 7.900 | 6.065 | 5.298 |
| 速動比率 (X) | 8.201 | 5.671 | 4.975 | 4.136 | 3.946 |
| 資產負債率 (%) | 9.294 | 11.089 | 10.563 | 13.276 | 15.557 |
| 帶息債務/全部投入資本 (%) | -2.434 | -2.225 | -0.654 | 1.024 | 0.704 |
| 股東權益/帶息債務 (%) | -4,068.134 | -4,435.120 | -14,863.128 | 9,308.957 | 13,501.109 |
| 股東權益/負債合計 (%) | 977.463 | 802.064 | 840.232 | 657.760 | 545.117 |
| 利息保障倍數 (X) | -120.926 | -31.468 | -30.840 | -3.857 | 38.525 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 56.430 | 56.541 | 78.390 | 75.078 | 75.332 |
| 存貨周轉天數 (天) | 173.734 | 268.752 | 199.089 | 119.244 | 123.871 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 03/06/2025 16:00 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
